Sarcopenia Treatment Market 2022, Increasing Geriatric Population Across Worldwide

According to Precision Business Insights (PBI), the latest report, the sarcopenia treatment market is expected to be valued at USD 2775.2 million in 2022 and is poised to grow at a significant CAGR of 6.4% over 2022-2028. The primary driver of the expansion of the global Sarcopenia Treatment market are the rising geriatric population, increase in malnutrition and vitamin deficiency in developing countries, and growing per capita healthcare expenditure.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/sarcopenia-treatment-market/

Protein Supplement Treatment Segment to Dominate the Sarcopenia Treatment Market:
Based on treatment type, Protein supplement treatment registered the highest market share and is expected to dominate the market over the forecast period. As, protein is the only structural and functional constituent found in all organs and cells, thus its requirement is anticipated to rise in the future. Protein supplements help in the maintenance of muscular mass, strength, and endurance. Its numerous benefits to the body undoubtedly increase the demand for the protein supplement segment. Consequently sarcopenia treatment market would expect to expand over the forecasted period.

North America Sarcopenia Treatment Market
North America accounted for a significant market share in the global sarcopenia treatment market and is anticipated to lead the market due to the increasing prevalence of sarcopenia is substantial among the aged population in this region, the existence of better healthcare facilities, and technological advancements. Asia-Pacific is also expected to grow at the maximum CAGR over the forecast period owing to an increase in the number of elderly age people, making a huge investment in research activities, and encouraging awareness in developing countries like India and China.

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players:
The global Sarcopenia Treatment market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In January 2022, MyMD Pharmaceuticals, Inc. was awarded the United States Patent 11,219,620 B2, titled "Method of Treating Sarcopenia." by the United States Patent and Trademark Office (USPTO).

Request sample report at: https://precisionbusinessinsights.com/request-sample?product_id=62946

The Sarcopenia Treatment market is segmented based on treatment type, route of administration, distribution channel, and geography.
Based on the treatment type, the market is segmented into the following:
• Protein Supplement
• Vitamin B12 Supplement
• Vitamin D & Calcium Supplement
• Others

Based on the route of administration, the market is segmented into the following:
• Oral
• Parenteral
• Enteral

Based on the distribution channel, the market is segmented into the following:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Based on geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

Request Methodology: https://precisionbusinessinsights.com/request-methodology?product_id=62946

Key players' profiles in the sarcopenia treatment market report are GlaxoSmithKline plc, Nestle Health Science, Sanofi S.A., Bayer AG, Cadila Healthcare Ltd, Eli Lilly and Company, GlaxoSmithKline plc., Sanofi, Novartis AG, Pfizer Inc., AstaReal AB, Merck Sharp & Dohme Corp., and AbbVie Inc.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 85278174

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and produce high-quality research reports. We have over five hundred clients with a good business partnership the capacity to provide in-depth research analysis for more than thirty countries. In addition to delivering more than 150 custom solutions, we already have accounts with the top five medical device manufacturers. Precision Business Insights offers cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and our services.

This release was published on openPR.